Covid19_DEI's profile picture. 🦠#COVID19 Drug Evidence Initiative | 📋Updated trial summary infographics for #healthcare providers | 🧑‍⚕️Founded by UofT Pharmacy students & alumni

Covid-19 Drug Evidence Initiative (CDEI)

@Covid19_DEI

🦠#COVID19 Drug Evidence Initiative | 📋Updated trial summary infographics for #healthcare providers | 🧑‍⚕️Founded by UofT Pharmacy students & alumni

Pinned

Check us out at cdei.ca !!

This team of fourth year #uoftpharmacy students created a new initiative to identify, evaluate and communicate evidence from #COVID19 treatment trials, helping to make the latest research accessible to those who need it. Read more: ow.ly/zKwO50zHgkj



The CDEI team would like to announce that we will no longer be reviewing new RCTs for COVID-19 drugs/vaccines. At this time we plan to keep the trial archive on our website at cdei.ca. A big thank you to our reviewing team, our expert advisors & you, our followers

Covid19_DEI's tweet image. The CDEI team would like to announce that we will no longer be reviewing new RCTs for COVID-19 drugs/vaccines. At this time we plan to keep the trial archive on our website at cdei.ca. A big thank you to our reviewing team, our expert advisors & you, our followers

Thank you @GeriMedRisk - it was a great presentation by Sandra and Karen!

This team of fourth year #uoftpharmacy students created a new initiative to identify, evaluate and communicate evidence from #COVID19 treatment trials, helping to make the latest research accessible to those who need it. Read more: ow.ly/zKwO50zHgkj



Our PICO, appraisal, and limitations for this trial looking at #progesterone plus standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #progesterone plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #progesterone plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #progesterone plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at a variation of the following: #lopinavir, #ritonavir, #azithromycin, #doxycycline, #hydroxychloroquine vs. standard of care (single dose azithromycin) for #COVID19 #RCT #TwitteRx #clinicatrial #evidencebasedmedicine

Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at a variation of the following: #lopinavir, #ritonavir, #azithromycin, #doxycycline, #hydroxychloroquine vs. standard of care (single dose azithromycin) for #COVID19

#RCT #TwitteRx #clinicatrial #evidencebasedmedicine
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at a variation of the following: #lopinavir, #ritonavir, #azithromycin, #doxycycline, #hydroxychloroquine vs. standard of care (single dose azithromycin) for #COVID19

#RCT #TwitteRx #clinicatrial #evidencebasedmedicine
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at a variation of the following: #lopinavir, #ritonavir, #azithromycin, #doxycycline, #hydroxychloroquine vs. standard of care (single dose azithromycin) for #COVID19

#RCT #TwitteRx #clinicatrial #evidencebasedmedicine

A special thank you to our reviewers and co-founders for their many hours of work over the past (almost) year!

This team of fourth year #uoftpharmacy students created a new initiative to identify, evaluate and communicate evidence from #COVID19 treatment trials, helping to make the latest research accessible to those who need it. Read more: ow.ly/zKwO50zHgkj



Our PICO, appraisal, and limitations for this trial looking at #proxalutamide plus standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #proxalutamide plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #proxalutamide plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #proxalutamide plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #tocilizumab plus standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #tocilizumab plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #tocilizumab plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #tocilizumab plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #azithromycin plus standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #azithromycin plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #azithromycin plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx
Covid19_DEI's tweet image. Our PICO, appraisal, and limitations for this trial looking at #azithromycin plus standard of care vs. standard of care for #COVID19 treatment.

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

*VACCINE REVIEW* Our outline, appraisal, and limitations for #Gamaleya’s interim report of their #COVID19 vaccine #Sputnik. Subscribe for future COVID-19 vaccine/treatment RCT updates at CDEI.ca! #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #Gamaleya

Covid19_DEI's tweet image. *VACCINE REVIEW*
Our outline, appraisal, and limitations for #Gamaleya’s interim report of their #COVID19 vaccine #Sputnik. Subscribe for future COVID-19 vaccine/treatment RCT updates at CDEI.ca! 

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #Gamaleya
Covid19_DEI's tweet image. *VACCINE REVIEW*
Our outline, appraisal, and limitations for #Gamaleya’s interim report of their #COVID19 vaccine #Sputnik. Subscribe for future COVID-19 vaccine/treatment RCT updates at CDEI.ca! 

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #Gamaleya
Covid19_DEI's tweet image. *VACCINE REVIEW*
Our outline, appraisal, and limitations for #Gamaleya’s interim report of their #COVID19 vaccine #Sputnik. Subscribe for future COVID-19 vaccine/treatment RCT updates at CDEI.ca! 

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #Gamaleya
Covid19_DEI's tweet image. *VACCINE REVIEW*
Our outline, appraisal, and limitations for #Gamaleya’s interim report of their #COVID19 vaccine #Sputnik. Subscribe for future COVID-19 vaccine/treatment RCT updates at CDEI.ca! 

#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #Gamaleya

You can catch the review we did at CDEI.ca, and here is our infographic for the #OxfordAstraZeneca #COVID19 vaccine! #COVIDRx #COVID19Vacines #TwitterRx #MedTwitter

Covid19_DEI's tweet image. You can catch the review we did at CDEI.ca, and here is our infographic for the #OxfordAstraZeneca #COVID19 vaccine!
#COVIDRx #COVID19Vacines #TwitterRx #MedTwitter
Covid19_DEI's tweet image. You can catch the review we did at CDEI.ca, and here is our infographic for the #OxfordAstraZeneca #COVID19 vaccine!
#COVIDRx #COVID19Vacines #TwitterRx #MedTwitter
Covid19_DEI's tweet image. You can catch the review we did at CDEI.ca, and here is our infographic for the #OxfordAstraZeneca #COVID19 vaccine!
#COVIDRx #COVID19Vacines #TwitterRx #MedTwitter

BREAKING: Health Canada has now approved use of the #COVID19 vaccine from AstraZeneca, clearing the way for millions more vaccinations across the country. cbc.ca/news/politics/…



United States Trends

Loading...

Something went wrong.


Something went wrong.